Maressa Alejandro-Reyes, MD
Geriatric Medicine · Elkhart, INNPI 1750328969
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $579 and has fallen 64.3% since, to $207 in 2025.
Across 51 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$207
- Boston Scientific$138
- QOL Medical, LLC$113
- Organon$112
- Amgen$103
- Abbott$87
- plus $417 from 15 others
What the payments were for
- Food & beverage$1,178100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $207 |
| Boston Scientific | 1 | $138 |
| QOL Medical, LLC | 4 | $113 |
| Organon | 7 | $112 |
| Amgen | 6 | $103 |
| Abbott | 4 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $59 |
| Organogenesis Inc. | 2 | $54 |
| Johnson & Johnson | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Sanofi | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Exact Sciences | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,178 in reported general payments places this provider in the 80th percentile of 70 geriatric medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $16,546 |
| Gabapentin | 42 | $1,451 |
| Atorvastatin Calcium | 100 | $758 |
| Ibandronate Sodium | 17 | $718 |
| Lisinopril | 54 | $514 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $486 |
| Pantoprazole Sodium | 55 | $463 |
| Amlodipine Besylate | 67 | $455 |
| Tizanidine Hcl | 13 | $446 |
| Omeprazole | 17 | $427 |
| Buspirone Hcl | 20 | $412 |
| Levothyroxine Sodium | 60 | $403 |
| Sucralfate | 13 | $356 |
| Losartan Potassium | 25 | $318 |
| Fluticasone Propionate | 11 | $257 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Elkhart
- Malaz BoustaniIndianapolis$188K
- Gregory SpanglerKokomo$31K
- Jodie HarperIndianapolis$27K
- Karl SashEvansville$26K
- Arnold del PilarMishawaka$25K
- Lauren DandurandMerrillville$11K
- Jack BartoszekMishawaka$7K
- Elton AmosIndianapolis$7K
- Kofi QuistIndianapolis$5K
- Robert LebowIndianapolis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.